Kalypsys has promoted John McKearn, former chief scientific officer, to president and CSO, the company announced last week. McKearn joined Kalypsys in July 2003 from Pharmacia, where he was senior vice president of research.
Kalypsys also added two new members to its board of directors, Kenneth Langone and Al Heller.
Langone is the co-founder and current board member of Home Depot, and is currently the president, CEO, and chairman of Invemed Associates, an investor in Kalypsys’ series B financing.
Heller is an investment advisor for life sciences transactions to One Equity Partners, a JPMorganChase company. He has over 27 years of healthcare experience, Kalypsys said, including most recently with Baxter Healthcare as senior vice president and president of its renal division.
John Leone will be the new president and CEO of Cambrex, effective August 23, the company said last week.
Leone joins Cambrex from Aventis, where he most recently served as president of its dermatology division, and prior to that, as senior vice president and chief operating officer of US commercial operations. He has a BS in engineering from the US Military Academy at West Point, and an MBA from the University of Colorado.
Leone replaces James Mack, who served as president and CEO since 1995. Mack, who was appointed chairman of the board of directors in 1999, will remain in this position until April 2005.
Cambrex also said that its board of directors has appointed Gary Mossman to the position of executive vice president and chief operating officer. Mossman joined Cambrex in 2003, and served as president and CEO of its pharma and biopharmaceuticals businesses.
Serologicals has named Robert Brown as vice president of corporate development, the company announced last week.
Most recently, Brown was senior vice president of corporate development at Andrx. He also worked for 15 years with Bristol-Myers Squibb, where his experience included leading its corporate development function for the US. Brown holds a BS in chemistry from Neumann College.